Diagnosis and treatment of acute tubular necrosis

Annals of Internal Medicine

Volumn 137, Issue 9, 2002, Pages 744-752

  Esson, Matthew L ^a   Schrier, Robert W ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIBIOTIC AGENT; ATRIAL NATRIURETIC FACTOR; CONTRAST MEDIUM; DIURETIC AGENT; DOPAMINE; NONSTEROID ANTIINFLAMMATORY AGENT; VASOACTIVE AGENT;

ACUTE KIDNEY FAILURE; ACUTE KIDNEY TUBULE NECROSIS; ADULT RESPIRATORY DISTRESS SYNDROME; BLADDER CATHETERIZATION; CAUSE OF DEATH; DIALYSIS; DRUG CONTRAINDICATION; EARLY DIAGNOSIS; ENTERIC FEEDING; FOLLOW UP; HUMAN; LUNG EDEMA; MALNUTRITION; MEDICAL LITERATURE; MEDICAL SPECIALIST; MEDLINE; MORTALITY; MULTIPLE ORGAN FAILURE; NEPHROLOGY; NEPHROTOXICITY; NONHUMAN; NUTRITIONAL SUPPORT; PARENTERAL NUTRITION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; REVIEW; SEPSIS; SODIUM EXCRETION; SURVIVAL; URINE SEDIMENT; VEIN CATHETERIZATION; VENTILATOR;

EID: 0037027454     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-137-9-200211050-00010     Document Type: Review

References (117)

1. Thadhani R, Pascual M, Bonventre JV. Acute renal failure. N Engl J Med. 1996;334:1448-60. [PMID: 8618585]
2. Liaño F, Pascual J. Epidemiology of acute renal failure: A prospective, multicenter, community-based study. Madrid Acute Renal Failure Study Group. Kidney Int. 1996;50:811-8. [PMID: 8872955]
3. Anderson R, Schrier RW. Acute renal failure. In: Schrier RW, ed. Diseases of the Kidney and Urinary Tract. 7th Ed. Philadelphia: Lippincott Williams & Wilkins; 2001.
4. Moran SM, Myers BD. Course of acute renal failure studied by a model of creatinine kinetics. Kidney Int. 1985;27:928-37. [PMID: 4021321]
5. Myers BD, Moran SM. Hemodynamically mediated acute renal failure. N Engl J Med. 1986;314:97-105. [PMID: 3510383]
6. Mehta RL. Acute renal failure in the intensive care unit: Which outcomes should we measure? Am J Kidney Dis. 1996;28(Suppl 3):S74-80.
7. Feest TG, Round A, Hamad S. Incidence of severe acute renal failure in adults: Results of a community based study. BMJ. 1993;306:481-3. [PMID: 8448456]
8. Schrier RW, Abraham E. Aggressive volume expansion and pseudo-ARDS [Editorial]. Hosp Pract (Off Ed). 1995;30:19, 23. [PMID: 7782392]
9. Miller TR, Anderson RJ, Linas SL, Henrich WL, Berns AS, Gabow PA, et al. Urinary diagnostic indices in acute renal failure: A prospective study. Ann Intern Med. 1978;89:47-50. [PMID: 666184]
10. Corwin HL, Schreiber MJ, Fang LS. Low fractional excretion of sodium. Occurrence with hemoglobinuric- and myoglobinuric-induced acute renal failure. Arch Intern Med. 1984;144:981-2. [PMID: 6712414]
11. Fang LS, Sirota RA, Ebert TH, Lichtenstein NS. Low fractional excretion of sodium with contrast media-induced acute renal failure. Arch Intern Med. 1980;140:531-3. [PMID: 7362385]
12. Zarich S, Fang LS, Diamond JR. Fractional excretion of sodium. Exceptions to its diagnostic value. Arch Intern Med. 1985;145:108-12. [PMID: 3970621]
13. Vaz AJ. Low fractional excretion of urine sodium in acute renal failure due to sepsis. Arch Intern Med. 1983;143:738-9. [PMID: 6838295]
14. Liano F, Junco E, Pascual J, Madero R, Verde E. The spectrum of acute renal failure in the intensive care unit compared with that seen in other settings. The Madrid Acute Renal Failure Study Group. Kidney Int. 1998;53(Suppl 66):S16-24.
15. Bonomini V, Stefoni S, Vangelista A. Long-term patient and renal prognosis in acute renal failure. Nephron. 1984;36:169-72. [PMID: 6700808]
16. Kjellstrand CM, Ebben J, Davin T. Time of death, recovery of renal function, development of chronic renal failure and need for chronic hemodialysis in patients with acute tubular necrosis. Trans Am Soc Artif Intern Organs. 1981;27:45-50. [PMID: 7331111]
17. Druml W, Lax F, Grimm G, Schneeweiss B, Lenz K, Laggner AN. Acute renal failure in the elderly 1975-1990. Clin Nephrol. 1994;41:342-9. [PMID: 8076437]
18. Chertow GM, Christiansen CL, Cleary PD, Munro C, Lazarus JM. Prognostic stratification in critically ill patients with acute renal failure requiring dialysis. Arch Intern Med. 1995;155:1505-11. [PMID: 7605152]
19. Brivet FG, Kleinknecht DJ, Loirat P, Landais PJ. Acute renal failure in intensive care units - Causes, outcome, and prognostic factors of hospital mortality; a prospective, multicenter study. French Study Group on Acute Renal Failure. Crit Care Med. 1996;24:192-8. [PMID: 8605788]
20. Neveu H, Kleinknecht D, Brivet F, Loirat P, Landais P. Prognostic factors in acute renal failure due to sepsis. Results of a prospective multicentre study. The French Study Group on Acute Renal Failure. Nephrol Dial Transplant. 1996;11:293-9. [PMID: 8700363]
21. Liaño F, Gallego A, Pascual J, García-Martín F, Teruel JL, Marcén R, et al. Prognosis of acute tubular necrosis: An extended prospectively contrasted study. Nephron. 1993;63:21-31. [PMID: 8446248]
22. Paganini EP, Halstenberg WK, Goormastic M. Risk modeling in acute renal failure requiring dialysis: The introduction of a new model. Clin Nephrol. 1996;46:206-11. [PMID: 8879857]
23. Chertow GM, Lazarus JM, Paganini EP, Allgren RL, Lafayette RA, Sayegh MH. Predictors of mortality and the provision of dialysis in patients with acute tubular necrosis. The Auriculin Anaritide Acute Renal Failure Study Group. J Am Soc Nephrol. 1998;9:692-8. [PMID: 9555672]
24. Paganini EP, Tapolyai M, Goormastic M, Halstenberg W, Kozlowski L, Leblanc M, et al. Establishing a dialysis therapy/patient outcome link in intensive care unit acute dialysis for patients with acute renal failure. Am J Kidney Dis. 1996;28(Suppl 3):S81-9.
25. Douma CE, Redekop WK, van der Meulen JH, van Olden RW, Haeck J, Struijk DG, et al. Predicting mortality in intensive care patients with acute renal failure treated with dialysis. J Am Soc Nephrol. 1997;8:111-7. [PMID: 9013455]
26. Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality. A cohort analysis. JAMA. 1996;275:1489-94. [PMID: 8622223]
27. Molitoris BA, Weinberg JM, Venkatachalam MA, Zager RA, Nath KA, Goligorsky MS. Acute renal failure. II. Experimental models of acute renal failure: Imperfect but indispensable. Am J Physiol. 2000;278:F1-12.
28. Star RA. Treatment of acute renal failure. Kidney Int. 1998;54:1817-31. [PMID: 9853246]
29. DuBose TD Jr, Warnock DG, Mehta RL, Bonventre JV, Hammerman MR, Molitoris BA, et al. Acute renal failure in the 21st century: Recommendations for management and outcomes assessment. Am J Kidney Dis. 1997;29:793-9. [PMID: 9159318]
30. Kelly KJ, Molitoris BA. Acute renal failure in the new millennium: Time to consider combination therapy. Semin Nephrol. 2000;20:4-19. [PMID: 10651214]
31. Alkhunaizi AM, Schrier RW. Management of acute renal failure: New perspectives. Am J Kidney Dis. 1996;28:315-28. [PMID: 8804228]
32. Rudnick MR, Goldfarb S, Wexler L, Ludbrook PA, Murphy MJ, Halpern EF, et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: A randomized trial. The lohexol Cooperative Study. Kidney Int. 1995;47:254-61. [PMID: 7731155]
33. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med. 2000;343:180-4. [PMID: 10900277]
34. van Valenberg PL, Hoitsma AJ, Tiggeler RG, Berden JH, van Lier HJ, Koene RA. Mannitol as an indispensable constituent of an intraoperative hydration protocol for the prevention of acute renal failure after renal cadaveric transplantation. Transplantation. 1987;44:784-8. [PMID: 3122381]
35. Duggan KA, Macdonald GJ, Charlesworth JA, Pussell BA. Verapamil prevents posttransplant oliguric renal failure. Clin Nephrol. 1985;24:289-91. [PMID: 3907910]
36. Wagner K, Albrecht S, Neumayer HH. Prevention of posttransplant acute tubular necrosis by the calcium antagonist diltiazem: A prospective randomized study. Am J Nephrol. 1987;7:287-91. [PMID: 3318461]
37. Neumayer HH, Wagner K. Prevention of delayed graft function in cadaver kidney transplants by diltiazem: Outcome of two prospective, randomized clinical trials. J Cardiovasc Pharmacol. 1987;10(Suppl 10):S170-7.
38. Dawidson I, Rooth P, Lu C, Sagalowsky A, Diller K, Palmer B, et al. Verapamil improves the outcome after cadaver renal transplantation. J Am Soc Nephrol. 1991;2:983-90. [PMID: 1760541]
39. Alcaraz A, Oppenheimer F, Talbot-Wright R, Fernández-Cruz L, Mañalich M, García-Pagés E, et al. Effect of diltiazem in the prevention of acute tubular necrosis, acute rejection, and cyclosporine levels. Transplant Proc. 1991;23:2383-4. [PMID: 1926395]
40. Tenschert W, Harfmann P, Meyer-Moldenhauer WH, Arndt R, Klosterhalfen H. Kidney protective effect of diltiazem after renal transplantation with long cold ischemia time and triple-drug immunosuppression. Transplant Proc. 1991;23:1334-5. [PMID: 1989231]
41. Donnelly Pk, Feehally J, Jurewicz A, Furness P, McCullough T, Harper SJ, et al. Renal transplantation: Nifedipine for the nonstarters? A prospective randomised study. Transplant Proc. 1993;25:600-1. [PMID: 8438431]
42. Lustig S, Shmueli D, Boner G, Bar-Nathan N, Nakache R, Yussim A, et al. Gallopamil reduces the posttransplantation acute tubular necrosis in kidneys from aged donors. Isr J Med Sci. 1996;32:1249-51. [PMID: 9007165]
43. Chan C, Maurer J, Cardella C, Cattran D, Pei Y. A randomized controlled trial of verapamil on cyclosporine nephrotoxicity in heart and lung transplant recipients. Transplantation. 1997;63:1435-40. [PMID: 9175807]
44. Henderson IS, Beattie TJ, Kennedy AC. Dopamine hydrochloride in oliguric states. Lancet. 1980;2:827-8. [PMID: 6107501]
45. Flancbaum L, Choban PS, Dasta JF. Quantitative effects of low-dose dopamine on urine output in oliguric surgical intensive care unit patients. Crit Care Med. 1994;22:61-8. [PMID: 8124976]
46. Pavoni V, Verri M, Fenaro L, Volta CA, Paparella L, Capuzzo M, et al. Plasma dopamine concentration and effects of low dopamine doses on urinary output after major vascular surgery. Kidney Int. 1998;53(Suppl 66):S75-80.
47. Marik PE. Low-dose dopamine in critically ill oliguric patients: The influence of the renin-angiotensin system. Heart Lung. 1993;22:171-5. [PMID: 8449762]
48. Lindner A. Synergism of dopamine and furosemide in diuretic-resistant, oliguric acute renal failure. Nephron. 1983;33:121-6. [PMID: 6835459]
49. Parker S, Carlon GC, Isaacs M, Howland WS, Kahn RC. Dopamine administration in oliguria and oliguric renal failure. Crit Care Med. 1981;9:630-2. [PMID: 7273808]
50. Epstein M, Schneider NS, Befeler B. Effect of intrarenal furosemide on renal function and intrarenal hemodynamics in acute renal failure. Am J Med. 1975;58:510-6. [PMID: 1124788]
51. Kleinknecht D, Ganeval D, Gonzalez-Duque LA, Fermanian J. Furosemide in acute oliguric renal failure. A controlled trial. Nephron. 1976;17:51-8. [PMID: 778649]
52. Brown CB, Ogg CS, Cameron JS. High dose furosemide in acute renal failure: A controlled trial. Clin Nephrol. 1981;15:90-6. [PMID: 7011622]
53. Shilliday IR, Quinn KJ, Allison ME. Loop diuretics in the management of acute renal failure: A prospective, double-blind, placebo controlled, randomized study. Nephrol Dial Transplant. 1997;12:2592-6. [PMID: 9430857]
54. Chiao H, Kohda Y, McLeroy P, Craig L, Housini I, Star RA. Alphamelanocyte-stimulating hormone protects against renal injury after ischemia in mice and rats. J Clin Invest. 1997;99:1165-72. [PMID: 9077523]
55. Chiao H, Kohda Y, McLeroy P, Craig L, Linas S, Star RA. Alpha-melanocyte-stimulating hormone inhibits renal injury in the absence of neutrophils. Kidney Int. 1998;54:765-74. [PMID: 9734601]
56. Schafferhans K, Heidbreder E, Grimm D, Heidland A. Norepinephrineinduced acute renal failure: Beneficial effects of atrial natriuretic factor. Nephron. 1986;44:240-4. [PMID: 2946967]
57. Nakamoto M, Shapiro JI, Shanley PF, Chan L, Schrier RW. In vitro and in vivo protective effect of atriopeptin III on ischemic acute renal failure. J Clin Invest. 1987;80:698-705. [PMID: 2957391]
58. Rahman SN, Kim GE, Mathew AS, Goldberg CA, Allgren R, Schrier RW, et al. Effects of atrial natriuretic peptide in clinical acute renal failure. Kidney Int. 1994;45:1731-8. [PMID: 793382]]
59. Allgren RL, Marbury TC, Rahman SN, Weisberg LS, Fenves AZ, Lafayette RA, et al. Anaritide in acute tubular necrosis. Auriculin Anaritide Acute Renal Failure Study Group. N Engl J Med. 1997;336:828-34. [PMID: 9062091]
60. Lewis J, Salem MM, Chertow GM, Weisberg LS, McGrew F, Marbury TC, et al. Atrial natriuretic factor in oliguric acute renal failure. Anaritide Acute Renal Failure Study Group. Am J Kidney Dis. 2000;36:767-74. [PMID: 11007679]
61. Hirschberg R, Kopple J, Lipsett P, Benjamin E, Minei J, Albertson T, et al. Multicenter clinical trial of recombinant human insulin-like growth Factor I in patients with acute renal failure. Kidney Int. 1999;55:2423-32. [PMID: 10354291]
62. Acker CG, Singh AR, Flick RP, Bernardini J, Greenberg A, Johnson JP. A trial of thyroxine in acute renal failure. Kidney Int. 2000;57:293-8. [PMID: 10620211]
63. Solez K, Morel-Maroger L, Sraer JD. The morphology of "acute tubular necrosis" in man: Analysis of 57 renal biopsies and a comparison with the glycerol model. Medicine (Baltimore). 1979;58:362-76. [PMID: 481195]
64. Adams PL, Adams FF, Bell PD, Navar LG. Impaired renal blood flow autoregulation in ischemic acute renal failure. Kidney Int. 1980;18:68-76. [PMID: 7218661]
65. Conger JD, Robinette JB, Schrier RW. Smooth muscle calcium and endothelium-derived relaxing factor in the abnormal vascular responses of acute renal failure. J Clin Invest. 1988;82:532-7. [PMID: 3261301]
66. Kelleher SP, Robinette JB, Conger JD. Sympathetic nervous system in the loss of autoregulation in acute renal failure. Am J Physiol. 1984;246:F379-86. [PMID: 6720897]
67. Conger JD, Schultz MF, Miller F, Robinette JB. Responses to hemorrhagic arterial pressure reduction in different ischemic renal failure models. Kidney Int. 1994;46:318-23. [PMID: 7967342]
68. Wu AW, Rubin HR, Rosen MJ. Are elderly people less responsive to intensive care? J Am Geriatr Soc. 1990;38:621-7. [PMID: 2358623]
69. Zion MM, Balkin J, Rosenmann D, Goldbourt U, Reicher-Reiss H, Kaplinsky E, et al. Use of pulmonary artery catheters in patients with acute myocardial infarction. Analysis of experience in 5,841 patients in the SPRINT Registry. SPRINT Study Group. Chest. 1990;98:1331-5. [PMID: 2245670]
70. Polanczyk CA, Rohde LE, Goldman L, Cook EF, Thomas EJ, Marcantonio ER, et al. Right heart catheterization and cardiac complications in patients undergoing noncardiac surgery: An observational study. JAMA. 2001;286:309-14. [PMID: 11466096]
71. Connors AF Jr, Speroff T, Dawson NV, Thomas C, Harrell FE Jr, Wagner D, et al. The effectiveness of right heart catheterizition in the initial care of critically ill patients. SUPPORT Investigators. JAMA. 1996;276:889-97. [PMID: 8782638]
72. Dalen JE, Bone RC. Is it time to pull the pulmonary artery catheter? [Editorial] JAMA. 1996;276:916-8. [PMID: 8782643]
73. Hayes MA, Timmins AC, Yau EH, Palazzo M, Hinds CJ, Watson D. Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med. 1994;330:1717-22. [PMID: 7993413]
74. Gattinoni L, Brazzi L, Pelosi P, Latini R, Tognoni G, Pesenti A, et al. A trial of goal-oriented hemodynamic therapy in critically ill patients. SrO2 Collaborative Group. N Engl J Med. 1995;333:1025-32. [PMID: 7675044]
75. Heyland DK, Cook DJ, King D, Kernerman P, Brun-Buisson C. Maximizing oxygen delivery in critically ill patients: A methodologic appraisal of the evidence. Crit Care Med. 1996;24:517-24. [PMID: 8625644]
76. Hébert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med. 1999;340:409-17. [PMID: 9971864]
77. Rudis MI, Basha MA, Zarowitz BJ. Is it time to reposition vasopressors and inotropes in sepsis? Crit Care Med. 1996;24:525-37. [PMID: 8625645]
78. Abizaid AS, Clark CE, Mintz GS, Dosa S, Popma JJ, Pichard AD, et al. Effects of dopamine and aminophylline on contrast-induced acute renal failure after coronary angioplasty in patients with preexisting renal insufficiency. Am J Cardiol. 1999;83:260-3, A5. [PMID: 10073832]
79. Chertow GM, Sayegh MH, Allgren RL, Lazarus JM. Is the administration of dopamine associated with adverse or favorable outcomes in acute renal failure? Auriculin Anaritide Acute Renal Failure Study Group. Am J Med. 1996;101:49-53. [PMID: 8686714]
80. Denton MD, Chertow GM, Brady HR. "Renal-dose" dopamine for the treatment of acute renal failure: Scientific rationale, experimental studies and clinical trials. Kidney Int. 1996;50:4-14. [PMID: 8807566]
81. Lassnigg A, Donner E, Grubhofer G, Presterl E, Druml W, Hiesmayr M. Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol. 2000;11:97-104. [PMID: 10616845]
82. Bellomo R, Chapman M, Finfer S, Hiclding K, Myburgh J. Low-dose dopamine in patients with early renal dysfunction: A placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet. 2000;356:2139-43. [PMID: 11191541]
83. Leverve X, Bamoud D. Stress metabolism and nutritional support in acute renal failure. Kidney Int. 1998;53(Suppl 66):S62-6.
84. Cerra FB, Benitez MR, Blackburn GL, Irwin RS, Jeejeebhoy K, Katz DP, et al. Applied nutrition in ICU patients. A consensus statement of the American College of Chest Physicians. Chest. 1997;111:769-78. [PMID: 9118718]
85. Moore FA, Moore EE, Jones TN, McCroskey BL, Peterson VM. TEN versus TPN following major abdominal trauma-reduced septic morbidity. J Trauma. 1989;29:916-22; discussion 922-3. [PMID: 2501509]
86. Sandström R, Drott C, Hyltander A, Arfvidsson B, Scherstén T, Wickström I, et al. The effect of postoperative intravenous feeding (TPN) on outcome following major surgery evaluated in a randomized study. Ann Surg. 1993;217: 185-95. [PMID: 8439216]
87. Perioperative total parenteral nutrition in surgical patients. The Veterans Affairs Total Parenteral Nutrition Cooperative Study Group. N Engl J Med. 1991;325:525-32. [PMID: 1906987]
88. Heyland DK, MacDonald S, Keefe L, Drover JW. Total parenteral nutrition in the critically ill patient: A meta-analysis. JAMA. 1998;280:2013-9. [PMID: 9863853]
89. Battistella FD, Widergren JT, Anderson JT, Siepler JK, Weber JC, MacColl K. A prospective, randomized trial of intravenous fat emulsion administration in trauma victims requiring total parenteral nutrition. J Trauma. 1997;43:52-8; discussion 58-60. [PMID: 9253908]
90. Conger JD. Interventions in clinical acute renal failure: What are the data? Am J Kidney Dis. 1995;26:565-76. [PMID: 7573008]
91. Abel RM, Beck CH Jr, Abbott WM, Ryan JA Jr, Barnett GO, Fischer JE. Improved survival from acute renal failure after treatment with intravenous essential L-amino acids and glucose. Results of a prospective, double-blind study. N Engl J Med. 1973;288:695-9. [PMID: 4631743]
92. Feinstein EI, Blumenkrantz MJ, Healy M, Koffler A, Silberman H, Massry SG, et al. Clinical and metabolic responses to parenteral nutrition in acute renal failure. A controlled double-blind study. Medicine (Baltimore). 1981;60:124-37. [PMID: 6783809]
93. Feinstein EI, Kopple JD, Silberman H, Massry SG. Total parenteral nutrition with high or low nitrogen intakes in patients with acute renal failure. Kidney Int. 1983;26(Suppl 16):S319-23.
94. Bellomo R, Seacombe J, Daskalakis M, Farmer M, Wright C, Parkin G, et al. A prospective comparative study of moderate versus high protein intake for critically ill patients with acute renal failure. Ren Fail. 1997;19:111-20. [PMID: 9044457]
95. Sponsel H, Conger JD. Is parenteral nutrition therapy of value in acute renal failure patients? Am J Kidney Dis. 1995;25:96-102. [PMID: 7810542]
96. Kopple JD. The nutrition management of the patient with acute renal failure. JPEN J Parenter Enteral Nutr. 1996;20:3-12. [PMID: 8788257]
97. Conger J. Dialysis and related therapies. Semin Nephrol. 1998;18:533-40. [PMID: 9754606]
98. Hakim RM. Clinical implications of hemodialysis membrane biocompatibility [Editorial]. Kidney Int. 1993;44:484-94. [PMID: 8231020]
99. Schiffl H, Lang SM, König A, Strasser T, Haider MC, Held E. Biocompatible membranes in acute renal failure: Prospective case- controlled study. Lancet. 1994;344:570-2. [PMID: 7914959]
100. Hakim RM, Wingard RL, Parker RA. Effect of the dialysis membrane in the treatment of patients with acute renal failure. N Engl J Med. 1994;331:1338-42. [PMID: 7935703]
101. Himmelfarb J, Tolkoff Rubin N, Chandran P, Parker RA, Wingard RL, Hakim R. A multicenter comparison of dialysis membranes in the treatment of acute renal failure requiring dialysis. J Am Soc Nephrol. 1998;9:257-66. [PMID: 9527402]
102. Kurtal H, von Herrath D, Schaefer K. Is the choice of membrane important for patients with acute renal failure requiring hemodialysis? Artif Organs. 1995;19:391-4. [PMID: 7625915]
103. Jones CH, Newstead CG, Goutcher E, Will EJ, Dean SG, Davison AM. Continuous dialysis for ARF in the ICU: Choice of membrane does not influence survival [Abstract]. J Am Soc Nephrol. 1997;8:126A.
104. Jörres A, Gahl GM, Dobis C, Polenakovic MH, Cakalaroski K, Rutkowski B, et al. Haemodialysis-membrane biocompatibility and mortality of patients with dialysis-dependent acute renal failure: A prospective randomised multicentre trial. International Multicentre Study Group. Lancet. 1999;354:1337-41. [PMID: 10533862]
105. Gastaldello K, Melot C, Kahn RJ, Vanherweghem JL, Vincent JL, Tielemans C. Comparison of cellulose diacetate and polysulfone membranes in the outcome of acute renal failure. A prospective randomized study. Nephrol Dial Transplant. 2000;15:224-30. [PMID: 10648669]
106. McCarthy JT. Prognosis of patients with acute renal failure in the intensive-care unit: A tale of two eras. Mayo Clin Proc. 1996;71:117-26. [PMID: 8577185]
107. Kleinknecht D, Jungers P, Chanard J, Barbanel C, Ganeval D. Uremic and nonuremic complications in acute renal failure: Evaluation of early and frequent dialysis on prognosis. Kidney Int. 1972;1:190-6. [PMID: 4545907]
108. Conger JD. A controlled evaluation of prophylactic dialysis in posttraumatic acute renal failure. J Trauma. 1975;15:1056-63. [PMID: 1202238]
109. Gillum DM, Dixon BS, Yanover MJ, Kelleher SP, Shapiro MD, Benedetti RG, et al. The role of intensive dialysis in acute renal failure. Clin Nephrol. 1986;25:249-55. [PMID: 3720035]
110. Schiffl H, Lang S, Konig A, Held E. Dose of intermittent hemodialysis and outcome of acute renal failure: A prospective randomized study [Abstract]. J Am Soc Nephrol. 1997;8:290A.
111. Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: A prospective randomised trial. Lancet. 2000;356:26-30. [PMID: 10892761]
112. Schiffl H, Lang SM, Fischer R. Daily hemodialysis and the outcome of acute renal failure. N Engl J Med. 2002;346:305-10. [PMID: 11821506]
113. Bonventre JV. Daily hemodialysis - Will treatment each day improve the outcome in patients with acute renal failure? [Editorial] N Engl J Med. 2002;346:362-4. [PMID: 1821514]
114. Lamiere N, Van Biesen W, Vanholder R, Colardijn F. The place of intermittent hemodialysis in the treatment of acute renal failure in the ICU patient. Kidney Int. 1998;53(Suppl 66):S110-9.
115. Forni LG, Hilton PJ. Continuous hemofiltration in the treatment of acute renal failure. N Engl J Med. 1997;336:1303-9. [PMID: 9113935]
116. Swartz RD, Messana JM, Orzol S, Port FK. Comparing continuous hemofiltration with hemodialysis in patients with severe acute renal failure. Am J Kidney Dis. 1999;34:424-32. [PMID: 1046985]]
117. Mehta R, McDonald B, Gabbai F, Pahl M, Parkas A, Pascual M, et al. Continuous versus intermittent dialysis for acute renal failure (ARF) in the ICU: Results from a randomized multicenter trial [Abstract]. J Am Soc Nephrol. 1996;7:A1044.